Photodynamic therapy for chronic central serous chorioretinopathy.

Détails

ID Serval
serval:BIB_1ABDA47363D9
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Titre
Photodynamic therapy for chronic central serous chorioretinopathy.
Périodique
Retina
Auteur⸱e⸱s
Cardillo Piccolino F., Eandi C.M., Ventre L., Rigault de la Longrais R.C., Grignolo F.M.
ISSN
0275-004X (Print)
ISSN-L
0275-004X
Statut éditorial
Publié
Date de publication
12/2003
Peer-reviewed
Oui
Volume
23
Numéro
6
Pages
752-763
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Résumé
To determine whether photodynamic therapy (PDT) is effective for treatment of chronic central serous chorioretinopathy (CSC).
Sixteen eyes with chronic CSC and macular detachment documented by optical coherence tomography (OCT) received PDT guided by indocyanine green (ICG) angiography according to the parameters outlined in the TAP Study. One or more laser spots were applied to the areas of choroidal vascular hyperpermeability that corresponded to retinal pigment epithelium decompensation. Patients were observed for 6 to 12 months. Two PDT sessions 1 month apart were performed on 2 eyes. Examinations included visual acuity measurement, fundus biomicroscopy, fluorescein and ICG angiography, and OCT.
Macular exudation resolved completely in 13 eyes (81%) and partially regressed in 3. Choriocapillaris hypoperfusion was shown by ICG angiography for several months at the site of PDT application. Visual acuity improved 1 to 4 lines in 11 eyes and was unchanged in 5 eyes.
ICG-guided PDT performed according to the parameters outlined by the TAP Study seems effective for treating chronic CSC. Further studies are needed to verify treatment safety and the time and rate of recurrences.
Mots-clé
Aged, Choroid Diseases/diagnosis, Choroid Diseases/drug therapy, Chronic Disease, Female, Fluorescein Angiography, Follow-Up Studies, Humans, Indocyanine Green, Male, Middle Aged, Photochemotherapy, Photosensitizing Agents/therapeutic use, Porphyrins/therapeutic use, Retinal Detachment/diagnosis, Retinal Detachment/drug therapy, Retinal Diseases/diagnosis, Retinal Diseases/drug therapy, Tomography, Optical Coherence, Treatment Outcome, Verteporfin, Visual Acuity
Pubmed
Web of science
Création de la notice
11/03/2021 14:13
Dernière modification de la notice
26/03/2021 7:35
Données d'usage